Scripps Research team finds that a nontoxic molecule closely related to resveratrol can overcome barriers to delivering gene therapy into stem cells
A study in animals similar in size to humans brings us a step closer to the clinical use of antibody gene therapy
CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs)
Ready-to-use kit enables lentivirus titer determinations during the manufacture of lentivirus vectors
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation
The new system, dubbed RESCUE, allows RNA edits to be made that were not previously possible
New vessel is designed for gentle stirring and optimum growth of cell lines
Current gene-editing tools rely on cutting DNA, but those cuts can lead to errors
Innovate UK-funded project supports development of scalable, cost effective production of regenerative medicines
Salk Institute and University of Florida researchers image a virus with better resolution than ever accomplished before
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature